Skip to main content

Healthcare systems

12-09-2022 | Primary care | News

Diabetes remission code may hamper care quality

Formal recognition of type 2 diabetes remission in primary care may lead to suboptimal health monitoring, a study suggests.

Close up of man hands using lancet to check blood sugar level with stack of coins. Health care cost concept.

10-17-2022 | Healthcare costs | News

Cost drives one in six US adults to ration insulin

Findings from a nationally representative US survey show that a substantial minority of people with diabetes ration their use of insulin because of issues with affordability.

Piggy bank balancing on seesaw over a bottle of pills

10-04-2022 | Healthcare costs | News

First-line SGLT2 inhibitors, GLP-1 receptor agonists ‘not cost effective’

The authors of a modeling study say that the price of SGLT2 inhibitors and GLP-1 receptor agonists would need to fall “by at least 70%” for them to be cost effective as first-line treatments in the USA.

09-13-2022 | Risk factors | News

Subjective energy levels predict cardiovascular events in type 2 diabetes

Researchers find that a single questionnaire item assessing vitality predicts major adverse cardiovascular events in people with type 2 diabetes.

08-22-2022 | COVID-19 | News

Glucokinase activator may improve severe COVID-19 outcomes in people with diabetes

Findings from the phase 2 ARCADIA trial suggest that treatment with a glucokinase activator may aid the recovery of people with diabetes who are hospitalized with severe COVID-19.

08-15-2022 | Comorbidities | News

Clinical complexity increasing in diabetes

Clinical complexity and treatment burden have both increased over recent years among people with diabetes in the USA, say researchers.

Diabetes care during the Covid-19 pandemic concept

05-31-2022 | COVID-19 | News

Pandemic diabetes care disruption linked to elevated mortality risk

The disruption of routine diabetes care during the pandemic may have resulted in an increased risk for mortality from causes not linked to COVID-19, research suggests.

04-01-2022 | DUKPC 2022 | Conference coverage | News

CVD-focused SGLT2 inhibitor prescribing failing to take hold

The proven cardiovascular benefits of SGLT2 inhibitors has not led doctors to prioritize their use in people at high risk, show findings from UK general practice.